LIPI Gene Hypertriglyceridemia susceptibility to Genetic Test
Components
Test Name: LIPI Gene Hypertriglyceridemia susceptibility to Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for LIPI Gene Hypertriglyceridemia, susceptibility to NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with Hypertriglyceridemia, susceptibility to
Test Details
LIPI (Lipase I) Gene Hypertriglyceridemia, susceptibility to NGS Genetic Test is a genetic test that analyzes variations in the LIPI gene to determine an individual’s susceptibility to hypertriglyceridemia. Hypertriglyceridemia is a condition characterized by high levels of triglycerides in the blood, which is a type of fat. It is often associated with an increased risk of cardiovascular disease and pancreatitis.
The LIPI gene provides instructions for producing the lipase I enzyme, which plays a crucial role in breaking down triglycerides in the body. Variations or mutations in the LIPI gene can affect the function of the lipase I enzyme, leading to impaired triglyceride metabolism and an increased risk of hypertriglyceridemia.
The NGS (Next-Generation Sequencing) technology used in this genetic test allows for the analysis of multiple genes simultaneously, providing a comprehensive assessment of an individual’s genetic predisposition to hypertriglyceridemia. By identifying specific variations in the LIPI gene, healthcare providers can better understand an individual’s risk of developing hypertriglyceridemia and tailor appropriate preventive measures or treatment strategies accordingly.
This information can be particularly useful in guiding lifestyle modifications, medication choices, and overall disease management for individuals at risk of hypertriglyceridemia.
| Test Name | LIPI Gene Hypertriglyceridemia susceptibility to Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for LIPI Gene Hypertriglyceridemia, susceptibility to NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypertriglyceridemia, susceptibility to |
| Test Details |
LIPI (Lipase I) Gene Hypertriglyceridemia, susceptibility to NGS Genetic Test is a genetic test that analyzes variations in the LIPI gene to determine an individual’s susceptibility to hypertriglyceridemia. Hypertriglyceridemia is a condition characterized by high levels of triglycerides in the blood, which is a type of fat. It is often associated with an increased risk of cardiovascular disease and pancreatitis. The LIPI gene provides instructions for producing the lipase I enzyme, which plays a crucial role in breaking down triglycerides in the body. Variations or mutations in the LIPI gene can affect the function of the lipase I enzyme, leading to impaired triglyceride metabolism and an increased risk of hypertriglyceridemia. The NGS (Next-Generation Sequencing) technology used in this genetic test allows for the analysis of multiple genes simultaneously, providing a comprehensive assessment of an individual’s genetic predisposition to hypertriglyceridemia. By identifying specific variations in the LIPI gene, healthcare providers can better understand an individual’s risk of developing hypertriglyceridemia and tailor appropriate preventive measures or treatment strategies accordingly. This information can be particularly useful in guiding lifestyle modifications, medication choices, and overall disease management for individuals at risk of hypertriglyceridemia. |
